Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay

Model NO.
CAS: 857890-39-2
Transport Package
by Express; by Air; by Sea
Specification
As customer′s requirment
Origin
China
HS Code
2933490090
Production Capacity
10kg
Reference Price
$ 27.00 - 36.00
Contact Us

Product Description

Supply lenvatinib Mesylate CAS:857890-39-2;98%~99% Assay 
Product Description
Product Name:    lenvatinib Mesylate
Synonyms: lenvatinib Methanesulfonate;E7080 Mesylate;4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide monomethanesulfonate;4-[3chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate;CAT#A863437;Lenvatinib Mesylate,Amadis Chemical offer CAS#857890-39-2;lenvatinib Mesylate;E7080;E-7080;E 7080
CAS:          857890-39-2
MF:  C22H23ClN4O7S
MW: 522.95862
EINECS:    812-398-0
Product Categories:      FGF receptor antagonist;API;API
Mol File:    857890-39-2.mol
Description Developed by Eisai Inc., lenvatinib mesylate is a vascular endothelial growth factor receptor (VEGF) inhibitor which has activity against VEGF subtypes 1, 2, and 3 and was approved by the FDA in 2015 for the treatment of differentiated thyroid cancer that is either locally recurrent, metastatic, or progressive and did not respond to radioactive iodine treatment. In May 2016, the FDA approved the drug as a combination therapy with everolimus for the treatment of advanced renal cell carcinoma. Because VEGF (and fibroblast growth factor receptors, known as FGFRs) are thought to play a role in cardiovascular signaling pathways, VEGF2R and FGFR inhibition are thought to be the mechanisms behind the primary side effect of lenvatinib mesylate, which is hypertension.
Uses E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively.
 
Packaging & Shipping
 
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
 
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay




 

 

Company Profile

 

Jinan Shengqi Pharmaceutical Co., Ltd ,it is a collection of research,production and sales ,specialized in APIs,Intermediates and fine chemicals 's enterprise. The head office is located in beautiful city-Jinan;traffic developed, rich human resources, information flow ,it has good political,economic cultural's foundation.It's good for us to selling products and created good conditions for the development of enterprise. The company own the muti-functional production workshop,outstanding sales team,and strong technology's R&D center; Production,sales & research suplement each other,it will promote the company's rapid development.
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
Supply Lenvatinib Mesylate CAS: 857890-39-2; 98%~99% Assay
  
Our Advantages

 

Pharmaceutical Intermediate

PNEUTEC.IT, 2023